Clinical Trial Update: UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment [Phase 2]

View source ↗

Summary

Phase II prospective evaluation of bone remodeling during ixazomib treatment in patients with multiple myeloma completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ixazomib (ixazomib)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2021-05-14